In the Mount Sinai division of Pediatric Gastroenterology and Hepatology, searching for answers is part of who we are. Our team is continually striving to advance our knowledge of digestive and liver diseases through research. At the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, our team takes a multi-faceted approach to researching IBD. Current areas of study include the microbial influences, genetic components, and treatment of IBD. Not all of our studies involve looking through a microscope. Our team is also studying how delivery of care can impact children living and coping with IBD.
Here are just a few of the studies currently underway in the division of Pediatric Gastroenterology and Hepatology.
- Precision IFX: Using a Pharmacokinetic Dashboard to Optimize and Individualize Infliximab Dosage for Pediatric Inflammatory Bowel Disease Patients
- Improving Transition Readiness in Pediatric IBD with Novel Behavioral Interventions
- Road to Prevention: A Mount Sinai IBD Initiative.
The Road to Prevention Program (RTP) at Mount Sinai encompasses multiple projects that individually and synergistically explore the concept of life before IBD. RTP focuses on the period of time before the development of overt IBD in high risk populations to identify predictors of disease. Learn more
- Correlation Between Vedolizumab Serum Levels, Anti-Vedolizumab Antibodies and Disease Activity in Subjects with IBD
- The Impact of anti-TNF Exposure on Vedolizumab Effectiveness: A Biomarker Study
- Phase 2, open-Label, multicenter, single arm study to investigate the safety and efficacy of Sofosbuvir+Ribavirin in adolescents and children with genotype 2 or 3 chronic HCV infection
- Phase 2, Open-Label, Multicenter, Multi-cohort study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination in Adolescents and Children with Chronic HCV genotype 1 Infection
- Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial